◀ Back to RHOA
ARHGEF25 — RHOA
Pathways - manually collected, often from reviews:
-
NCI Pathway Database Regulation of RhoA activity:
GEFT (ARHGEF25)
→
RHOA/GTP complex (RHOA)
(modification, activates)
Lutz et al., Naunyn Schmiedebergs Arch Pharmacol 2004*, Lutz et al., J Biol Chem 2005*, Lutz et al., Science 2007*, Swenson-Fields et al., Mol Cell 2008*
Evidence: assay, physical interaction
-
NCI Pathway Database Regulation of RhoA activity:
GEFT (ARHGEF25)
→
RHOA/GDP complex (RHOA)
(modification, activates)
Lutz et al., Naunyn Schmiedebergs Arch Pharmacol 2004*, Lutz et al., J Biol Chem 2005*, Lutz et al., Science 2007*, Swenson-Fields et al., Mol Cell 2008*
Evidence: assay, physical interaction
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Souchet et al., J Cell Sci 2002
:
In vitro guanine nucleotide exchange assays have shown that
p63RhoGEF specifically
acts on
RhoA ... Moreover, we show that
p63RhoGEF activation of
RhoA in intact cells is dependent on the presence of the PH domain
Lutz et al., Naunyn Schmiedebergs Arch Pharmacol 2004
(Urinary Bladder Neoplasms) :
When expressed in human embryonic kidney cells, both
p63RhoGEF and GEFT
caused activation of
RhoA , but not Rac1 or Cdc42, and induced serum response factor mediated gene transcription, which was fully blunted by the Rho inactivating C3 transferase
Lutz et al., J Biol Chem 2005
:
We further demonstrate that active G alpha ( q ) or G alpha11, but not G alpha12 or G alpha13, strongly enhances
p63RhoGEF induced
RhoA activation by direct protein-protein interaction with p63RhoGEF at its C-terminal half
Wuertz et al., FASEB J 2010
:
The purpose of our study was to investigate the
role of endogenous
p63RhoGEF in G ( q/11 ) -dependent
RhoA activation and signaling in rat aortic smooth muscle cells ( RASMCs )